DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Exemption Order in the matter of NGL Fine-Chem Limited

SEBI 1 hr ago·9 Oct 2026, 12:32 pm

NGL Fine Chem

NGL Fine-Chem Limited has received an exemption order regarding a specific regulatory matter. This development signals a positive shift for the company, as the exemption relieves it from certain penalties or restrictions that were previously applicable.

For investors, this news is significant because it removes a potential overhang on the stock. It suggests the company has successfully navigated a compliance issue, which can lead to improved operational focus and potentially better financial performance in the future.

Moving forward, investors should monitor the company's future regulatory filings to ensure the exemption remains in effect. Additionally, keeping an eye on the company's quarterly results will help determine if this regulatory clarity translates into tangible business growth.